lobbying_activities: 1075635

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1075635	04856c1a-4e24-4710-84ee-d1bb31393fb6	Q1	BUCHANAN INGERSOLL & ROONEY PC	55291	SHIRE PHARMACEUTICALS INC	2011	first_quarter	PHA	Life Sciences investment Act; Creating Hope Act; Pharma fees and orphan drug exclusion; ESRD bundling of non-injectable oral equivalents, ESRD Quality Incentive program; orphan drugs; health care reform implementation; ADHD awareness	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2011-04-14T11:49:18.457000-04:00